[New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
Beloborodova
N V
NV
Popov
D A
DA
Vostrikova
T Iu
TIu
Bachinskaia
E N
EN
Kuznetsova
S T
ST
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001372:Aza Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D004334:Drug Administration Schedule; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D000077266:Moxifloxacin; D011183:Postoperative Complications / Q000188:drug therapy* / Q000382:microbiology; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin